• Company
• HKinno.N exports new drug K-CAB technology to Brazil
• by Chon, Seung-Hyun Jan 30, 2023 05:54am

• Company
• SK Bioscience proposes building a vaccine hub in Middle East
• by Jan 30, 2023 05:54am

• Company
• Practice manual issued for COVID-19 treatments in Korea
• by Jan 30, 2023 05:54am

• Policy
• Price of Dutasteride has fallen to the 200 won range
• by Lee, Tak-Sun Jan 30, 2023 05:54am

• Company
• HK inno.N introduces biosimilar for Prolia & Xgeva
• by Lee, Seok-Jun Jan 27, 2023 05:51am

• Policy
• Negotiating Erleada's price with the NHIS
• by Lee, Tak-Sun Jan 27, 2023 05:51am

• Company
• Flu activity rises...revives Tamiflu market
• by Jan 27, 2023 05:51am

• Policy
• The copyrights of Valcyte, Alvesco, & Bonviva changed
• by Lee, Tak-Sun Jan 27, 2023 05:50am

• Company
• Will the 3 asthma biodrugs finally be reimbursed this year?
• by Eo, Yun-Ho Jan 27, 2023 05:50am

• Company
• JAKi Cibinqo attempts reimb in both adolescents and adults
• by Eo, Yun-Ho Jan 26, 2023 06:06am